Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 26.66
-0.13 (-0.49%)
Sep 18, 2025, 2:45 PM CST
SHE:300702 Revenue
Zhejiang Tianyu Pharmaceutical had revenue of 808.11M CNY in the quarter ending June 30, 2025, with 40.31% growth. This brings the company's revenue in the last twelve months to 2.93B, up 19.89% year-over-year. In the year 2024, Zhejiang Tianyu Pharmaceutical had annual revenue of 2.63B with 4.10% growth.
Revenue (ttm)
2.93B
Revenue Growth
+19.89%
P/S Ratio
3.14
Revenue / Employee
647.14K
Employees
4,532
Market Cap
9.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.63B | 103.54M | 4.10% |
| Dec 31, 2023 | 2.53B | -139.41M | -5.23% |
| Jan 1, 2023 | 2.67B | 121.67M | 4.78% |
| Jan 1, 2022 | 2.55B | -42.39M | -1.64% |
| Dec 31, 2020 | 2.59B | 476.80M | 22.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |